1,165 results on '"Bourdin, Arnaud"'
Search Results
52. CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma
53. Defining a Severe Asthma Super-Responder: Findings from a Delphi Process
54. Differentiating between active and latent tuberculosis with chest computed tomography
55. Identifier et prendre en charge l’asthme difficile
56. Prospective Multicenter Validation of the Detection of ALK Rearrangements of Circulating Tumor Cells for Noninvasive Longitudinal Management of Patients With Advanced NSCLC
57. Potential Severe Asthma Hidden in UK Primary Care
58. “Real-life” management of patients with severe asthma in the biologics era: Can we do better?
59. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
60. Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial
61. Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol Fumarate versus Other Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis
62. Healthcare Resource Utilization Associated with Intermittent Oral Corticosteroid Prescribing Patterns in Asthma.
63. Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors.
64. Prevalence of anti-neutrophil cytoplasmic antibody-associated vasculitis in the south of France, using the capture-recapture method.
65. Similarities and differences of interstitial lung disease associated with pathogenic variants in SFTPC and ABCA3 in adults.
66. Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study
67. International Severe Asthma Registry: Mission Statement
68. Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma
69. Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma
70. Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors
71. Multiple Biologics for Multiple T2 Diseases: A Pharmacoepidemiological Algorithm for Sorting Out Patients by Indication
72. Arterial Sleeve Lobectomy: Does Pulmonary Artery Reconstruction Type Impact Lung Function?
73. Adult Severe Asthma Registries: A Global and Growing Inventory
74. Mask side-effects in long-term CPAP-patients impact adherence and sleepiness: the InterfaceVent real-life study
75. Association between increased mortality and bronchial fibroscopy in intensive care units and intermediate care units during COPD exacerbations: an analysis of the 2014 and 2015 National French Medical-based Information System Databases (PMSI)
76. The Burden of Severe Asthma in France: A Case-Control Study Using a Medical Claims Database
77. Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma
78. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial
79. RV function improvement following nitric oxide inhalation demonstrated by gated blood pool SPECT in a patient with primary pulmonary hypertension
80. Outcomes and risk assessment in pulmonary veno-occlusive disease.
81. Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort.
82. Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort
83. Early COPD and Hedgehog interacting protein (HHIP) polymorphisms
84. Characteristics of exacerbations in patients with severe, uncontrolled asthma who received tezepelumab versus placebo
85. Late Breaking Abstract - Development of a bronchial epithelium with a sensory innervation both derived from induced pluripotent stem cells
86. Phenotypic characterization of interstitial lung disease associated with mutations in SFTPC and ABCA3 in adults
87. High-dose aspirin in severe uncontrolled asthma associated with chronic rhinosinusitis with nasal polyps (CRwNP) : the ASTHMIRINE trial
88. Benefits of bronchial epithelial repair by iPSC in COPD
89. Blunted vascular response to pulmonary rehabilitation in COPD patients and impaired exercise-induced mobilization of endothelial-colony forming cells
90. Lower respiratory tract involvement in recurrent respiratory papillomatosis in a multicentric cohort study
91. Sputum viscosity is correlated with Computed Tomography (CT) mucus score in muco-obstructive lung diseases
92. An algorithm to identify patients with T2 diseases and Chronic Spontaneous Urticaria treated with biologics in outpatient care setting using a dynamic dispensing database
93. Revisiting Peter Macklem's old dream through the PRISm of lung volumes
94. Elevated Blood Pressure Occurs without Endothelial Dysfunction in a Rat Model of Pulmonary Emphysema
95. The Transcriptome Landscape of the In Vitro Human Airway Epithelium Response to SARS-CoV-2
96. Longitudinal patterns of intermittent oral corticosteroid therapy for asthma in the United Kingdom
97. Impact of psychological factors on the health-related quality of life of patients treated for pulmonary arterial hypertension
98. A Randomized, Double-Blind, Double-Dummy Study of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Relative to Umeclidinium/Vilanterol Dry Powder Inhaler in COPD
99. Dapagliflozin initiation in chronic heart failure patients improves central sleep apnoea
100. What place will tezepelumab hold in the treatment paradigm in chronic rhinosinusitis?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.